Spontaneous and glucocorticoid (fluocinolone acetonide, FA)-induced apoptosis of primary mouse thymocytes was inhibited by protein kinase C (PKC) activators such as bryostatin-1 and phorbol ester 12-O-tetradecanoyl-phorbol-13 acetate (TPA) within the first 2^4 h of incubation but was enhanced upon prolonged treatment. Only the anti-apoptotic but not the pro-apoptotic effect of TPA was completely suppressed by the PKC inhibitor Goe 6983 and moderately inhibited by Goe 6976. Immunoblot analysis revealed distinct PKC K, L, N, R, a, W and j signals, a very faint PKCO and no PKCQ signal. Upon prolonged TPA treatment all PKC isoenzymes became downregulated, albeit at different rates (PKCN s K s W s L,aER,j). No significant generation of caspase-derived catalytic PKC fragments, as found to be produced upon induction of apoptosis and to be pro-apoptotic in other systems, was observed in FA-or TPA-treated thymocytes. It is concluded that the early antiapoptotic effect of TPA depends on the activation of n-type PKC isoenzymes, whereas stimulation of spontaneous and FAinduced apoptosis by TPA ensues, at least partially, from a downregulation (or inactivation) of anti-apoptotic PKC species, i.e. in primary thymocytes PKC activation is primarily involved in a negative regulation of apoptosis. ß
Introduction
A large body of evidence indicates a role of protein kinase C (PKC) isoenzymes in the induction and regulation of apoptosis (for reviews see [1^3] ). For a long time PKC was considered to exert mainly an anti-apoptotic e¡ect. This conclusion was predominantly based on experiments showing PKC inhibitors to induce and PKC activators (such as phorbol esters and bryostatin) to inhibit apoptosis. However, other results are in contrast to these observations, since they indicate a pro-apoptotic e¡ect of PKC activation. Recently, apoptosis of certain cell lines was found to correlate with partial proteolytic degradation of distinct PKC isoforms [3^9] . In some cases the constitutively active PKC fragment thus obtained induced apoptosis upon transfection of HeLa-and 220-8 cells. In apoptotic LNCaP prostate cancer cells, however, no partial degradation or PKCN was observed [10] . Instead, non-degraded PKCN was found to mediate apoptosis in these cells.
Most of these studies were carried out using established or transformed cell lines thus leaving the question of the physiological relevance of the results open. On the other hand, apoptosis of primary cells has also been reported to be in£uenced by PKC activation in either a positive or a negative manner. The presently best studied example is provided by primary thymocytes, a classical model of apoptosis research, in particular of glucocorticoid-induced cell death [11] . As far as an involvement of PKC in thymocyte apoptosis is concerned, con£icting results have been published. Thus, several groups reported on a pro-apoptotic e¡ect of phorbol esters and other PKC activators (see, for instance, [12^15]) and an anti-apoptotic e¡ect of kinase inhibitors, whereas other groups arrived at just the opposite results (reviewed in [16] ). The interpretation of such observations is hampered by the fact that phorbol esters not only activate PKC but, upon prolonged application, also downregulate PKC along proteolytic pathways. Therefore, it may critically depend on the experimental conditions whether a pro-apoptotic or an antiapoptotic e¡ect is observed. Another obstacle is the multiplicity of the mammalian PKC family which is grouped into three subfamilies, i.e. Ca 2 -and 12-Otetradecanoyl-phorbol-13 acetate (TPA)/diacylglycerol (DAG)-sensitive cPKCs (PKCK, LI, LII and Q), TPA/DAG-sensitive nPKCs (PKCN, O, R, a and the more distantly related PKCW/PKD), and TPA/DAGinsensitive aPKCs (PKCV and j). Upon activation, some PKC species may inhibit while others may promote apoptosis.
This con£icting situation prompted us to study the kinetics of the e¡ect of two PKC activators (phorbol ester TPA and bryostatin-1) on apoptosis and on downregulation of distinct PKC isoforms in primary mouse thymocytes in more detail and to address the question as to whether or not partial PKC degradation is involved in the induction of apoptosis. We arrive at the conclusion that in these cells PKC is primarily involved in a negative regulation of apoptosis.
Materials and methods

Materials
The phorbol ester TPA was kindly supplied by Dr. E. Hecker (DKFZ, Heidelberg, Germany). Bryostatin-1 was a generous gift of Dr. G.R. Petit (State University of Arizona, Tempe, AZ, USA).
Polyclonal antibodies against PKCL (sc-210), PKCN (sc-937), PKCQ (sc-211), PKCO (sc-214) and PKCR (sc-215) were obtained from Santa Cruz Biotechnology (Heidelberg, Germany), anti-PKCj (Y 9339) from Gibco BRL (Gaithersburg, MD, USA) (PKCj), and monoclonal antibodies against PKCK (P16 520), PKCN (P36520), PKCa (P15120) and PKCW (P26720) from Transduction Laboratories (Lexington, KY, USA). The PKC inhibitors Goe 6976 and Goe 6983 were obtained from Goedecke (Freiburg, Germany) and horse-radish peroxidaseconjugated anti-mouse and anti-rabbit antibodies from Dianova (Hamburg, Germany). The enhanced chemiluminescence (ECL) kit was obtained from Amersham (Brunswick, Germany). Other materials were purchased from Sigma (Munich, Germany).
Cells and treatment
Suspensions of thymocytes from female NMRI mice (age 4^7 weeks) were prepared according to [17] in RPMI 1640 medium supplemented with 5% heat-inactivated fetal bovine serum, 20 mM L-glutamine, 100 U/ml penicillin and 100 Wg/ml streptomycin. For the experiments, 10 7 cells/ml were used. Additives were dissolved in acetone (¢nal acetone concentration in the medium 0.1%) and the cells were incubated at 37³C, 5% CO 2 and 95% humidity for the times indicated. Human U937 cells were cultivated in RPMI 1640 medium containing 10% fetal calf serum as described in [9] .
Activity assay and immunoblotting of PKC
TPA-stimulated PKC activity was determined in Triton X-100 extracts from 1.2U10 7 thymocytes/ 1.5 ml extraction bu¡er [17] , according to [18] .
To discriminate PKC-catalyzed from non-PKCcatalyzed protein phosphorylation, phosphorylation assays without TPA/phosphatidyl serine were performed, the results of which were subtracted from the results obtained in the presence of the PKC activators. Extraction, electrophoretic separation and immunoblotting of PKC isoenzymes were carried out as described in [18] . The antibodies were diluted with phosphate-bu¡ered saline (PBS) containing 1% bovine serum albumin and 0.05% Tween 20 either 1:500 (polyclonal) or 1:1000 (monoclonal).
Fluorescence-activated cell scanning (FACS)
analysis of fragmented DNA Cells were centrifuged for 10 min at 800 rpm, resuspended in 1 ml PBS without Ca 2 and Mg 2 and precipitated in 14 ml ice-cold ethanol. After a minimum of 12 h at 4³C the cell pellet was centrifuged. After DNA staining with DAPI and protein counterstaining with SR101, FACS analysis was carried out following a protocol of Sto « hr et al. [19] .
Electrophoretic analysis of fragmented DNA
[20] 1^2U10 6 cells were centrifuged at 1000 rpm for 10 min, washed with PBS and incubated with lysis bu¡er (10 mM Tris/HCl, 1 mM EDTA, 0.2% Triton X-100, pH 7.5) at 0³C for 30 min. After centrifugation (13 000 rpm, 4³C, 10 min, Eppendorf centrifuge) the supernatant was mixed with the same volume of ice-cold isopropanol, 2^5 Wl glycogen (1 mg/ml water) and LiCl (¢nal concentration 1 M). The mixture was stored at 320³C for at least 1 h. Then the DNA was isolated by centrifugation (13 000 rpm, 15 min), washed twice with ice-cold ethanol and dissolved in 10 mM Tris/boric acid, pH 7.4, containing 1 mM EDTA. Electrophoresis in a 1.4% agarose gel was carried out as described by Sellins and Cohen [20] . The gels were stained with 1% ethidium bromide and photographed under UV light (254 nm).
Results and discussion
When immature thymocytes from female NMRI mice (age 4^7 weeks) were incubated with RPMI-1640 medium/5% fetal bovine serum, FACS analysis or agarose gel electrophoresis (Fig. 1) revealed a time-dependent increase of apoptotic DNA fragmentation which, depending on the cell preparation, reached values between 10 and 40% within 18 h. (Fig. 2) . This spontaneous apoptosis was strongly increased by the synthetic glucocorticoid £uocino-lone acetonide (FA, ED 50 = 0.5 nM). PKC activators such as the phorbol ester tumor promoter TPA and bryostatin-1 exhibited a biphasic e¡ect, i.e. both spontaneous as well as FA-induced DNA fragmentation were suppressed within the ¢rst 2^4 h and synergistically enhanced upon prolonged incubation (ED 50 = 0.5 nM, for both agents). Cell death as determined by the trypan blue exclusion assay followed FA-or TPA-induced DNA fragmentation with a delay of approximately 4 h (not shown). We did not ¢nd a long-term ( s 18 h) anti-apoptotic phorbol ester e¡ect as reported by others [16] even under exactly the same experimental conditions. To restrict the PKC isoforms mediating the e¡ects of TPA and bryostatin, experiments with the bisindolylmaleimide Goe 6983 and the indolcarbazole Goe 6976 were carried out. These potent and rather speci¢c PKC inhibitors have become valuable research tools since they allow discrimination, up to a certain degree, between subgroups of PKC isozymes [22^25]. As summarized in Table 1 , Goe 6983 is a strong inhibitor of all PKC isoforms tested so far, with the exception of PKCW, which is not inhibited. In contrast, Goe 6976 strongly inhibits both PKCW and cPKCs but is only a rather poor inhibitor of a-and nPKCs.
The initial inhibition of apoptosis by TPA was completely reversed by Goe 6983 indicating that this e¡ect was due to an activation of PKC with the exception of PKCW (Fig. 3) . As compared with Goe 6983 the agent Goe 6976 was considerably less e¡ective in this respect. Thus, the inhibitor experiments argue against an involvement of cPKC species or PKCW. Instead they indicate nPKC to mediate the anti-apoptotic e¡ect of the phorbol ester. The mechanism of this anti-apoptotic e¡ect is unknown, at least as primary thymocytes are concerned. Recently, a study on T cell lines [26] has indicated an activation of a MAP kinase-dependent signaling pathway and an impairment of CD95 receptor activation to be involved.
When applied together with TPA (not shown) or 4 h later (Fig. 3) both Goe-type inhibitors failed to suppress the stimulation of apoptosis by TPA as measured after 8 or 18 h or by FA as measured after 8 h (not shown). Moreover,`spontaneous' DNA fragmentation as measured in acetone-treated control cultures after 18 h was not inhibited but stimulated by the Goe-substances by about 50%. These results clearly indicate that only the early anti-apoptotic but not the delayed pro-apoptotic e¡ect of TPA was mediated by PKC and that an activation of PKC was not involved in the induction of spontaneous and FA-induced apoptosis either. They, moreover, suggest that the pro-apoptotic e¡ect of TPA was simply due to TPA-induced downregulation of antiapoptotic PKC species.
As shown in Fig. 4 , TPA-dependent PKC activity was indeed strongly downregulated in cell-free prep- arations from thymocytes treated with TPA or FA for 10^20 h whereby both agents acted in a synergistic manner. Immunoblot analysis revealed PKCK, L, N, R, W, a and j, but not PKCQ, to be expressed in mouse thymocytes (Fig. 5) . This result con¢rms and extends earlier observations [27^29] whereas, in contrast to another report [30] , only a very faint immune signal for PKCO was observed (not shown). Recently, we also found PKCV in thymocytes (unpublished results). Upon TPA or FA treatment the immune signals of all PKC species became downregulated, however at quite di¡erent kinetics (Fig. 5) . At the timepoint when the anti-apoptotic e¡ect of TPA (or bryostatin-1) had vanished, i.e. after 4 h in the absence and 2 h in the presence of glucocorticoid, only the immune signals of PKCR and j were found not to be diminished, whereas the signals of the other PKC species were already clearly reduced. These differences in the degradation kinetics of the individual PKC isoenzymes widely invalidate the argument, that PKC downregulation preceding apoptosis could Immunoblots showing the e¡ects of FA and TPA on the expression of PKC isoenzymes in mouse thymocytes. Thymocytes were prepared and treated as described for Fig. 2 . At the times indicated the proteins from 4W10 7 cells each were extracted and separated by means of 7% sodium dodecyl sulfate^polyacrylamide gel electrophoresis (160 Wg protein per slot). Western blots were prepared and stained with PKC isoenzyme-speci¢c antibodies. The decrease of the electrophoretic mobilities of PKCa and PKCW seen upon TPA treatment was most probably due to TPA-induced (auto)phosphorylation [17] . not be discriminated from downregulation resulting from apoptosis. In fact, degradation of PKCK and N clearly preceded the TPA-induced increase of DNA fragmentation, whereas a substantial downregulation of PKCR and PKCj coincided with cell death as demonstrated by the trypan blue exclusion test. In fact, PKCj and PKCR may be considered as internal standards of protein degradation occurring as a consequence of apoptosis. We therefore propose that the degradation of PKC in TPA-treated thymocytes occurs along two pathways, i.e. an early isoenzymespeci¢c downregulation induced by TPA, followed by protein degradation along the apoptotic pathway. If one tentatively assumes that the enhancement of apoptosis by TPA mainly is due to a downregulation of anti-apoptotic n-type PKC species (an alternative mechanism would be enzyme inactivation through posttranslational modi¢cation), PKCR and perhaps also PKCa could be ruled out since they were still widely present at a time point when the anti-apoptotic e¡ect of TPA had been replaced already by the pro-apoptotic e¡ect (i.e. after 4 h of incubation). Among the PKCs only PKCN was already strongly downregulated at this timepoint making it a candidate for the role of an anti-apoptotic mediator. Such a conclusion is, however, in contrast to other reports indicating an active role of PKCN in the execution of apoptosis, as, for instance, in human T cell lines [31] , human colon cancer cells [32] , salivary gland acinar cells [33] and LNCaP prostate cancer cells [10] . With one exception [10] this pro-apoptotic e¡ect of PKCN was shown to correlate with a partial proteolytic cleavage of the enzyme which may be required for the induction of apoptosis. In fact, in the human promonocytic cell line U937 the induction of apoptosis by 1-L-D-ara-binofuranosyl cytosine (ara-C) was found to yield a caspase-3-derived constitutively active 40 kDa fragment of PKCN which induced apoptosis upon transfection of HeLa cells [3^6] . Analogous results were obtained for PKCa [7] . Moreover, for gamma-irradiated thymocytes the appearance of a corresponding PKCR fragment was observed, an overexpression of which also induced apoptosis in 220-8 cells [8] . These observations have led to the hypothesis that, depending on the cell type and the apoptosis-inducing agent, a constitutive activation of PKC due to partial proteolysis is a critical event in apoptosis.
Using a C-terminal anti-PKCN antibody (sc-937), which recognizes the caspase-derived fragment, we also found an almost complete transformation of PKCN into a 40 kDa catalytic fragment in U937 cells, starting after 1 h and being complete 6 h after induction of apoptosis with tumor necrosis factor K (50 ng/ml) plus cycloheximide (5 Wg/ml). A partial degradation to a 62 kDa fragment was also found for PKCW in these cells [9] . However, no signi¢cant generation of corresponding fragments from PKCN, R, a or W was observed in mouse thymocytes treated for 2, 4 and 8 h with TPA as compared to control cells treated with acetone. Also FA treatment for up to 8 h did not induce a substantial formation of such fragments from PKCN, R and a; only for PKCW was a distinct signal of a 62 kDa fragment observed.
Beside these immunoblot data the inability of Goetype PKC inhibitors to suppress the pro-apoptotic e¡ect of TPA or FA strongly argues against an involvement of proteolytic PKC fragments in thymocyte apoptosis. These fragments still contain the ATP-binding site of the catalytic domain and should, therefore, be inhibited by the Goe type inhibitors. In fact, using PKCW autophosphorylation as an assay and Goe 6976 as an inhibitor we measured IC 50 values of 20 WM for the complete enzyme and 2 WM for the catalytic fragment.
Although our results are apparently at odds with another report showing a selective inhibitory e¡ect of Goe 6983 on thymocyte apoptosis induced by the PKC activator ingenol-3,20-dibenzoate [15] , we conclude that the induction of apoptosis by the phorbol ester is at least partially due to a downregulation or endogenous inactivation of anti-apoptotic PKC species. Such a permissive e¡ect is expected to favor spontaneous apoptosis or the pro-apoptotic e¡ect of factors in the cell culture medium. Moreover, it most easily explains that upon prolonged incubation ( s 4 h) FA-induced apoptosis was synergistically enhanced by TPA and that spontaneous apoptosis in control cultures was stimulated by Goe-type inhibitors. However, the stimulatory e¡ect of the inhibitors was not as strong as that of TPA and seen only upon prolonged incubation. This may indicate that, in addition to PKC inactivation, PKC-independent processes may participate in the pro-apoptotic e¡ect of the phorbol ester [34] .
Since TPA has become famous as a highly potent skin tumor promoter rather than an inducer of thymocyte apoptosis the question arises as to how a study on thymocytes may contribute to a better understanding of tumor development. As far as the tumor-promoting e¡ect of TPA is concerned contradictory hypotheses postulating a key role of either PKC activation [35] or PKC downregulation [36] have been put forward. However, no substantial PKC downregulation was found in the course of skin tumor promotion, i.e. upon chronic TPA treatment and in neoplastic lesions [37] . This ¢nding strongly indicates that the tumor-promoting e¤cacy of TPA depends on a repeated activation of PKC which, in analogy to the thymocyte model, may lead to a suppression of programmed cell death, whereas PKC downregulation would counteract such an e¡ect.
